Rob Krummen Presents Vektor Medical at LSI Europe '23

Step-by-Step Tutorial: Understanding Vektor Medical's Global Health Technology Vmap

Introduction:

1. Watch the YouTube video titled "Rob Krummen Presents Vektor Medical at LSI Europe '23" from the channel LSI - Life Science Intelligence™ to learn about Vektor Medical's global health technology Vmap.

Key Insights:

2. Vektor Medical's Vmap aims to address the global crisis of arrhythmias by offering solutions in three key areas:
   • Improving clinical outcomes in difficult cases.
   • Enhancing workflows and reducing procedure time in both challenging and routine cases.
   • Transforming arrhythmia understanding by utilizing ECG technology to move procedures upstream from EP labs to EP clinics.

Success Stories:

3. Learn about Jerry and Grant, two individuals who had unsuccessful ablations for arrhythmia until they found Vektor Medical's technology through an electrophysiologist in California.
4. Discover how Vmap helped Jerry and Grant achieve successful procedures, leading to a rhythm-free life for both individuals.

Global Impact of Arrhythmias:

5. Understand the significant impact of arrhythmias on global health, with 10% of global deaths attributed to cardiac arrhythmias.
6. Recognize the growing prevalence of arrhythmias and their associated risks, such as stroke and dementia, highlighting the urgent need for effective treatment solutions.

Treatment Challenges:

7. Explore the staggering statistics revealing that millions of people worldwide suffer from arrhythmias, surpassing the number of individuals living with cancer.
8. Acknowledge the treatment gap in arrhythmias and the importance of innovative solutions like Vmap to improve patient outcomes and procedural efficiency.

Vmap Technology:

9. Learn about Vmap as the first FDA-cleared, clinically validated, non-invasive AI-based solution that leverages 12-Lead ECG technology for improving ablation outcomes and procedural efficiency.
10. Understand the significance of utilizing 12-Lead ECG, a widely-used cardiology test, to enhance arrhythmia understanding and facilitate better access to care.

Computational Simulation:

11. Gain insights into Vektor Medical's computational simulation approach, bridging the gap in knowledge to enhance outcomes and support electrophysiologists in treatment decisions.
12. Explore the extensive computational library containing over a million data samples for successful procedures and collaborations with numerous healthcare centers across the United States.

Future Prospects:

13. Discover Vektor Medical's growth projections, including a target of $100 million in ARR by the end of electrophysiology, backed by a strong clinical foundation and a robust intellectual property portfolio.
14. Stay informed about Vektor Medical's ongoing innovations, such as AI and co-registration imaging, aimed at expanding their technology's reach and impact in the field of cardiac rhythm management.

Conclusion:

15. Stay updated on Vektor Medical's progress as they aim to obtain European C Mark and regulatory approvals for their cloud distribution system, contributing to the advancement of arrhythmia treatment globally.

Additional Information:

16. Connect with Vektor Medical at upcoming conferences to learn more about their innovative solutions and collaborations with leading experts in the field of electrophysiology.